相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
Jagoda K. Wrobel et al.
PHARMACEUTICALS (2020)
Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents
Angelina Sampson et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Overexpression of ERBB4 rejuvenates aged mesenchymal stem cells and enhances angiogenesis via PI3K/AKT and MAPK/ERK pathways
Xiaoting Liang et al.
FASEB JOURNAL (2019)
Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma
Peter Utnes et al.
CANCER INFORMATICS (2019)
Afatinib Decreases P-Glycoprotein Expression to Promote Adriamycin Toxicity of A549T Cells
Yan Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway
Ji Xu et al.
ONCOLOGY REPORTS (2018)
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Antoine Forget et al.
CANCER CELL (2018)
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
Jacqueline F. Donoghue et al.
CANCERS (2018)
Neuroblastoma is composed of two super-enhancer-associated differentiation states
Tim van Groningen et al.
NATURE GENETICS (2017)
ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation
Michael A. Schumacher et al.
CELL DEATH & DISEASE (2017)
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang et al.
CELL REPORTS (2017)
Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines (vol 4, 170033, 2017)
Jo Lynne Harenza et al.
SCIENTIFIC DATA (2017)
Factors associated with recurrence and survival length following relapse in patients with neuroblastoma
Nermine O. Basta et al.
BRITISH JOURNAL OF CANCER (2016)
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study
Barbara C. Worst et al.
EUROPEAN JOURNAL OF CANCER (2016)
Mutational dynamics between primary and relapse neuroblastomas
Alexander Schramm et al.
NATURE GENETICS (2015)
Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1
Sheng-qi Wang et al.
ONCOTARGET (2015)
In vivo knockdown of ErbB3 in mice inhibits Schwann cell precursor migration
Tomohiro Torii et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
Interaction of the Efflux Transporters ABCB1 and ABCG2 With Imatinib, Nilotinib, and Dasatinib
L. N. Eadie et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration
Jonathan W. Haskins et al.
SCIENCE SIGNALING (2014)
Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo
Xiao-kun Wang et al.
ONCOTARGET (2014)
The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem-cell-niche function
Joan Isern et al.
ELIFE (2014)
Factors Influencing the CNS Distribution of a Novel MEK-1/2 Inhibitor: Implications for Combination Therapy for Melanoma Brain Metastases
Shruthi Vaidhyanathan et al.
DRUG METABOLISM AND DISPOSITION (2014)
The prenatal origins of cancer
Glenn M. Marshall et al.
NATURE REVIEWS CANCER (2014)
P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal Sequestration
Tetsuo Yamagishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
Flavio Solca et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Function of ERBB4 is determined by alternative splicing
Ville Veikkolainen et al.
CELL CYCLE (2011)
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma
Kristina A. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
M. Michaelis et al.
CELL DEATH & DISEASE (2011)
ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
Fumin Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
Marius Dohse et al.
DRUG METABOLISM AND DISPOSITION (2010)
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study
A. K. Koutras et al.
BRITISH JOURNAL OF CANCER (2008)
Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB95-S and NB97
Barbara Hero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA
M Fischer et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: Implications in multidrug resistance in cancer
D Fu et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
P-glycoprotein: from genomics to mechanism
SV Ambudkar et al.
ONCOGENE (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
